Ritva L. Peltomaa
Helsinki, Finland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Differential joint-level response to secukinumab in psoriatic arthritis: A collaborative European observational cohort study.
Journal: EULAR rheumatology open
Published: June 29, 2026
CMR T1 and T2 mapping and extracellular volume quantification in systolic phase produces superior image quality with less motion artifacts and equal mapping values compared to conventional diastolic mapping.
Journal: Magma (New York, N.Y.)
Published: November 14, 2025
Clonal hematopoiesis is associated with distinct rheumatoid arthritis phenotypes.
Journal: Science advances
Published: April 30, 2025
Evolution of various inflammatory arthritis incidences during 2015-2020: A nationwide population-based register study in Finland.
Journal: Joint bone spine
Published: November 11, 2024
Challenge of missing data in observational studies: investigating cross-sectional imputation methods for assessing disease activity in axial spondyloarthritis.
Journal: RMD open
Published: August 06, 2024
Differences in the response to TNF inhibitors at distinct joint locations in patients with psoriatic arthritis: results from nine European registries.
Journal: Arthritis research & therapy
Published: July 13, 2024
Enthesitis in a European registry-based cohort of patients with psoriatic arthritis treated with tumour necrosis factor inhibitors: clinical burden, patient-reported outcomes, and treatment response.
Journal: Scandinavian journal of rheumatology
Published: May 21, 2024
Myocardial T1 mapping by cardiac magnetic resonance imaging shows early myocardial changes in treatment-naive patients with active rheumatoid arthritis and positive autoantibodies.
Journal: Clinical and experimental rheumatology
Published: August 29, 2023
Tofacitinib treatment modulates the levels of several inflammation-related plasma proteins in rheumatoid arthritis and baseline levels of soluble biomarkers associate with the treatment response.
Journal: Clinical and experimental immunology
Published: April 19, 2022
Short-term, intermediate-term and long-term risks of acute coronary syndrome in cohorts of patients with RA starting biologic DMARDs: results from four Nordic countries.
Journal: Annals of the rheumatic diseases
Published: December 13, 2021
Last Updated: 09/26/2026